Delivery Order SPE2DR25D6037-SPE2DR26FXL3D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Carbamazepine ER 200 mg tablets in quantities of 100 units, with a contract ceiling value of $2,807.07. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.34 to AmerisourceBergen Drug Corp for Carbamazepine ER 100 mg capsules (120-count supply) on December 29, 2025, with completion scheduled for December 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,074.80 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Carbamazepine ER 400 mg tablets in quantities of 100 units. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. As a...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.77 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of 1,000 tablets of Carbamazepine 200 mg. This is a firm fixed-price contract with an ultimate completion date of January 29, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Carbamazepine ER 400 mg tablets (100-count units) valued at $1,202.14, with an ultimate completion date of December 10, 2025. This award represents a non-competitive, non-set-aside procurement executed on December 9, 2025, with performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. Carbamazepine is an anticonvulsant medication commonly prescribed for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Carbamazepine ER 100 mg capsules (120-count) with a contract value of $1,591.22. The award represents a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,242.64. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,239.75 for Carbamazepine ER 200 mg tablets (100-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The place of performance is the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.45 to AmerisourceBergen Drug Corp for Carbamazepine 100 mg chewable tablets in quantities of 500, with an ultimate completion date of November 18, 2025. The contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of 4,563,961,909 carbamazepine ER 400 mg tablets in 100-count bottles, with a contract ceiling value of $6,012.55 and a performance period through March 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in...
- SPE2DR25D6037Indefinite Delivery Contract
- SPE2DR25D6037-SPE2DR26FXL3DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,152.00. This non-competitive, firm fixed-price delivery order is scheduled for completion by February 5, 2026, with performance conducted at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and operates through December 2026 as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company routinely fulfills delivery orders for a diverse portfolio of pharmaceutical products across multiple therapeutic domains through its prime indefinite delivery contract with DLA. This particular delivery order for a generic anticonvulsant medication reflects the contractor's ongoing role as a key supplier of both brand-name and generic medications to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/3/26 |